Skip to main content
. 2019 Nov 12;68(12):2067–2080. doi: 10.1007/s00262-019-02429-2

Fig. 6.

Fig. 6

Model depicting the structured tumor-immune microenvironment in MIBC patients with the infiltration of Gal-9+TAMs. As demonstrated in patients with high or low Gal-9+TAM level, we explore survival curves, chemotherapy effectiveness, specific immune contexture and immune regulation molecules. Two patterns of structured tumor-immune microenvironment are illustrated